cardiac arrest
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age =18 years old 2.Myocardial infarction was diagnosed at admission with ICD code I2X.X 3. Complete neutrophil, lymphocyte, and platelet count data at admission
Exclusion criteria
Exclusion criteria: 1. Patients with missing key variables 2. Changes in inflammatory or immune markers other than AMI (autoimmune diseases), trauma, recent major surgery 3. Only the first admission was included in the records of multiple admissions for the same patient during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systemic immune-inflammation index;neutrophile granulocyte;blood platelet count;lymphocyte; | — |
Secondary
| Measure | Time frame |
|---|---|
| hemameba;albumin;Blood sodium;serum potassium;blood calcium;blood glucose;anion gap;Blood gas Lactic acid;Blood gas oxygen partial pressure;Plasma prothrombin time;fibrinogen concentration;partial thromboplastin time;international normalized ratio;D-dimer;triglyceride;total cholesterol;high-density lipoprotein;low density lipoprotein;bilirubin;glutamic-pyruvic transaminase;glutamic oxalacetic transaminase;urea nitrogen;creatinine;Uric Acid;lactic dehydrogenase;creatine kinase;Creatine Kinase Isoenzyme;Cardiac troponin T;B-type natriuretic peptide;C-reactive protein;age;gender;height;weight;body temperature;hypertension;Diabetes mellitus type II;Diabetes mellitus type I;heart failure;cancer;chronic renal failure;acute renal failure;liver cirrhosis;hepatitis;phthisis;pneumonia;stroke;hyperlipemia;chronic bronchitis;systemic inflammatory response syndrome;multiple organ dysfunction syndrome;septicopyemia;heart rate;Noninvasive systolic blood pressure;Noninvasive diastolic blood pressure;Mean invasive blood pressure;oxyhemoglobin saturation;admission time;ICU admission time;Time out of ICU;Time of discharge;death time;Time of death during hospitalization;ICU death time;Duration of mechanical ventilation;antibiotic;hypotensive drugs;glucocorticoid;nephrotoxic drugs;immunosuppressor;anticoagulant drug;antiplatelet drugs;lipid-lowering drug;hypolycemic agent;enteral nutrition;Analgesic treatment;alteplase;dobutamine;dopamine;epinephrine;noradrenaline;phenylephrine;milrinone;antidiuretic;muscle relaxants;Sepsis-related Organ Failure;Simplified Acute Physiology Score II,;Glasgow Coma Scale;Liver function score;Cardiac function score; | — |
Countries
China
Contacts
Harbin Medical University Cancer Hospital